Palbociclib in treating patients with relapsed or Refractory Rb positive advanced solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic disorders with activating alterations in cell cycle genes (A Pediatric MATCH Treatment Trial). The gene discussed is RB1; the disease is non-Hodgkin lymphoma.